文献速递间质性肺疾病肺结节与肺癌

成人肺朗格汉斯细胞组织细胞增生症的长期结局:一项前瞻性队列研究

Long-term outcomes of adult pulmonary Langerhans cell histiocytosis: a prospective cohort.
PubMed 文献 · Eur Respir J · 2022-05-26

该前瞻性队列纳入2004至2018年法国国家组织细胞增生症参考中心新诊断的206例成人肺朗格汉斯细胞组织细胞增生症(PLCH)患者,中位随访5.1年。10年生存率为93%(95%CI 89-97%),慢性呼吸衰竭和/或肺动脉高压5年和10年累积发生率均<5%,肺癌标准化发病比为17.0(95%CI 7.45-38.7)。结论认为PLCH长期预后优于既往报道,但需密切监测严重并发症。

要点

  • 成人PLCH 10年生存率达93%,长期预后优于既往回顾性研究报道。
  • 慢性呼吸衰竭和/或肺动脉高压5年和10年累积发生率均<5%,但发生者中58%死亡。
  • 肺癌标准化发病比为17.0,诊断后需密切监测严重并发症及恶性肿瘤。

核心结论

  • 成人PLCH长期预后显著优于既往报道,但诊断后仍需密切监测以早期发现严重并发症。

研究设计与样本

  • 前瞻性队列研究纳入2004至2018年法国国家组织细胞增生症参考中心新诊断的206例成人PLCH患者,平均年龄39±13岁,60%为女性,95%为当前吸烟者,中位随访5.1年(IQR 3.2-7.6年)。

主要发现

  • 206例患者中12例(6%)死亡,10年生存率估计为93%(95%CI 89-97%)。
  • 慢性呼吸衰竭和/或肺动脉高压5年和10年累积发生率均<5%,这些患者中58%死亡。
  • 23例患者中观察到27种恶性肿瘤,肺癌标准化发病比为17.0(95%CI 7.45-38.7)。
  • 157例初诊孤立性PLCH患者中8例(5.1%)出现肺外受累。

临床怎么用

  • 成人PLCH患者长期生存较好,但应密切随访以早期发现慢性呼吸衰竭、肺动脉高压及恶性肿瘤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The long-term outcomes of adult pulmonary Langerhans cell histiocytosis (PLCH), particularly survival, are largely unknown. Two earlier retrospective studies reported a high rate of mortality, which contrasts with our clinical experience. METHODS: To address this issue, all patients with newly diagnosed PLCH referred to the French national reference centre for histiocytoses between 2004 and 2018 were eligible for inclusion. The primary outcome was survival, which was defined as the time from inclusion to lung transplantation or death from any cause. Secondary outcomes included the cumulative incidences of chronic respiratory failure (CRF), pulmonary hypertension (PH), malignant diseases and extrapulmonary involvement in initially isolated PLCH. Survival was estimated using the Kaplan-Meier method. RESULTS: 206 patients (mean age 39±13 years, 60% female, 95% current smokers) were prospectively followed for a median duration of 5.1 years (IQR 3.2-7.6 years). Of these, 12 patients (6%) died. The estimated rate of survival at 10 years was 93% (95% CI 89-97%). The cumulative incidences of CRF and/or PH were <5% at both 5 and 10 years, and 58% of these patients died. 27 malignancies were observed in 23 patients. The estimated standardised incidence ratio of lung carcinoma was 17.0 (95% CI 7.45-38.7) compared to an age- and sex-matched French population. Eight (5.1%) of the 157 patients with isolated PLCH developed extrapulmonary involvement. CONCLUSION: The long-term prognosis of PLCH is significantly more favourable than has previously been reported. Patients must be closely monitored after diagnosis to detect severe complications early.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Benattia A, Bugnet E, Walter-Petrich A, et al. Long-term outcomes of adult pulmonary Langerhans cell histiocytosis: a prospective cohort. Eur Respir J. 2022. PMID: 34675043. doi:10.1183/13993003.01017-2021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。